![Michael Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Henderson
Verkställande Direktör på
APOGEE THERAPEUTICS, INC.
Förmögenhet: 97 M $ per 2026-05-31
Profil
Michael Henderson is the founder of PellePharm, Inc., founded in 2011.
Dr. Henderson is currently Chief Executive Officer at QED Therapeutics, Inc. since 2017, Chief Executive Officer at Origin Biosciences, Inc. since 2018, Chief Executive Officer & Director at Apogee Therapeutics, Inc. since 2022 (title started in 2023), Independent Director at Spyre Therapeutics, Inc. since 2023, Director at Therasis, Inc. since 2016, Director at Quartz Therapeutics, Inc. since 2016, Director at Adrenas Therapeutics, Inc. since 2017, and Director at Bridgebio Oncology Therapeutics, Inc. since 2016.
Former positions include Independent Director at.
ARYA Sciences Acquisition Corp.
IV from 2021 to 2024, Senior Associate at McKinsey & Co., Inc. from 2015 to 2016, and Chief Business Officer at BridgeBio Pharma, Inc. from 2020 to 2022.
Education includes undergraduate studies at Harvard University and a doctorate from Stanford University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-10 | 1 095 987 ( 1,96 % ) | 90 M $ | 2026-05-31 | |
| 2026-05-27 | 88 606 ( 0,1 % ) | 7 M $ | 2026-05-31 |
Aktiva positioner av Michael Henderson
| Företag | Position | Start |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-06-22 |
| APOGEE THERAPEUTICS, INC. | Verkställande Direktör | 2022-09-01 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Verkställande Direktör | - |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Verkställande Direktör | - |
Therasis, Inc.
 Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Direktör/Styrelseledamot | 2016-09-01 |
Adrenas Therapeutics, Inc. | Direktör/Styrelseledamot | 2017-07-01 |
Quartz Therapeutics, Inc. | Direktör/Styrelseledamot | 2016-09-01 |
Tidigare kända positioner av Michael Henderson
| Företag | Position | Slut |
|---|---|---|
| ARYA SCIE | Direktör/Styrelseledamot | 2024-08-01 |
| BRIDGEBIO PHARMA, INC. | Företagsledare/Principal | 2022-09-01 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Michael Hendersons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
22
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
PellePharm, Inc.
 PellePharm, Inc. BiotechnologyHealth Technology Develops biotechnologies to cure dermatological diseases | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therasis, Inc.
Therasis, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Quartz Therapeutics, Inc. | |
Adrenas Therapeutics, Inc. | |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
